Paying users zone. Data is covered by hidden.

  • Get to Celgene Corp. for $13.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Statement of Financial Position, Assets

Difficulty: Beginner

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Celgene Corp., Consolidated Statement of Financial Position, Assets

USD $ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Cash and cash equivalents hidden hidden hidden hidden hidden
Marketable securities available-for-sale hidden hidden hidden hidden hidden
Accounts receivable, net of allowances hidden hidden hidden hidden hidden
Inventory hidden hidden hidden hidden hidden
Income tax receivable hidden hidden hidden hidden hidden
Other receivables hidden hidden hidden hidden hidden
Derivative assets hidden hidden hidden hidden hidden
Other prepaid taxes hidden hidden hidden hidden hidden
Prepaid income taxes hidden hidden hidden hidden hidden
Prepaid maintenance and software licenses hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Other current assets hidden hidden hidden hidden hidden
Current assets hidden hidden hidden hidden hidden
Property, plant and equipment, net hidden hidden hidden hidden hidden
Intangible assets, net hidden hidden hidden hidden hidden
Goodwill hidden hidden hidden hidden hidden
Other non-current assets hidden hidden hidden hidden hidden
Non-current assets hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-13).


Assets, Selected Items

Item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Celgene Corp.'s current assets increased from 2015 to 2016 and from 2016 to 2017.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Celgene Corp.'s property, plant and equipment, net increased from 2015 to 2016 and from 2016 to 2017.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Celgene Corp.'s non-current assets declined from 2015 to 2016 and from 2016 to 2017.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Celgene Corp.'s total assets increased from 2015 to 2016 and from 2016 to 2017.

Current Assets, Selected Items

Item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Celgene Corp.'s cash and cash equivalents increased from 2015 to 2016 and from 2016 to 2017.
Marketable securities available-for-sale Amount of investment in marketable security, classified as current. Celgene Corp.'s marketable securities available-for-sale increased from 2015 to 2016 and from 2016 to 2017.
Accounts receivable, net of allowances Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Celgene Corp.'s accounts receivable, net of allowances increased from 2015 to 2016 and from 2016 to 2017.
Inventory Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Celgene Corp.'s inventory increased from 2015 to 2016 and from 2016 to 2017.